Progress in Mind
- March 15-18, 2018
- Turin, Italy
- Lingotto Congress Center
Choose a channel
Check out the different Progress in Mind content channels.
Progress in Mind Resource Center reports from the first AAT- AD/PD congress.
Progress in Mind Resource Center brings you the latest research from the AAT-AD/PD focus meeting in Torino. This joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PD strives to present the latest research in Alzheimer's and Parkinson's Disease.
Stay tuned as the Congress highlights become available or sign-up to our newsletter to receive updates directly to your mailbox.
Parkinson's Disease
Read time: 3 min Article
New therapeutic technologies and targets for Parkinson’s disease
A gastroretentive capsule containing multiple layers of biodegradable film, intraoral infusion via...
Alzheimer's Disease
Read time: 3 min Article
How beneficial is cholinesterase inhibition and for whom?
New evidence suggests that cholinesterase inhibition in prodromal Alzheimer’s disease (AD)...
Alzheimer's Disease
Read time: 4 min Article
Biomarkers to enable early diagnosis and intervention and to monitor progression
Clinical diagnosis of Alzheimer’s disease (AD) is difficult and has an error rate of 40%....
Alzheimer's Disease, Parkinson's Disease
Read time: 3 min Article
Deep brain stimulation, transcranial magnetic stimulation and rhythmic auditory cues can improve motor symptoms, speech and gait
Nonpharmacological approaches for the treatment of neurodegenerative diseases were discussed at a...
Alzheimer's Disease
Read time: 2 min Article
Addressing challenges of dosage and administration in the development of disease-modifying therapy
Challenges in the development of disease-modifying therapy for Alzheimer’s disease (AD)...
Parkinson's Disease
Read time: 4 min Congress highlights
Advances in Parkinson’s disease research: one step closer to identify subjects in the prodromal stage, predicting conversion and potential for disease-modifying therapy
The incidence of Parkinson’s disease (PD) is increasing. The reasons are unknown. Identifying...
Alzheimer's Disease
Read time: 4 min Congress highlights
Could astrocyte activation initiate AD pathology 20 years before diagnosis?
Neuroimaging techniques demonstrate a 20-year pathophysiological pathway preceding the development...
Alzheimer's Disease, Parkinson's Disease
Read time: 3 min Congress highlights
Gut bacteria may trigger Alzheimer’s disease
The role of the gut and it’s microbiota in neurodegerenative diseases have gain a lot of...
Alzheimer's Disease
Read time: 3 min Congress highlights
Essential elements for Alzheimer’s disease clinical trials
Stronger links between novel agents and their targets, more precise selection of patients, and...
Alzheimer's Disease
Read time: 4 min Congress highlights
Dietary interventions that may lower the risk of Alzheimer’s disease
Increasing evidence shows that dietary interventions may lower the risk of developing Alzheimer...